Abstract
The presence of pharmaceuticals in drinking water has been a subject of concern for the last ten years because many of these pollutants are persistent in such aquatic matrices. Latest studies have shown that they can pose a ecotoxicological risk due to their potential long-term negative effects on living organism, even though the relatively low concentrations of these compounds in drinking water (ng/L). For this reason, several researchers have been investigating the roles of various drinking water treatment (DWT) processes in the efficiency of these polar pollutants elimination to decrease their release into the drinking water system. What more, from several years the monitoring programs and advance risk assessment are being carried out in order to gives important information for indicators finding (for future monitoring) and consequential regulations. This study critically reviews available literature on pharmaceutical residues in drinking water, starting from their occurrence, fate and finally toxicology significance. Presented review is also presenting the issue of pharmaceuticals detection and products occurred after drinking water treatment. Moreover, it is also intended to provide an proposition into what future directions might be taken by drinking-water regulators, governments, and water suppliers in their challenging task of enhancing the availability of data on the fate, behavior, and ecotoxicity of pharmaceutical residues in drinking water, in order to be fully aware of the potential risks to humans from exposure to traces of pharmaceuticals via drinking water.
Keywords: Drinking water, legislation, pharmaceutical residues, risk assessment, trace analysis.
Graphical Abstract
Current Analytical Chemistry
Title:Current Issues in Pharmaceutical Residues in Drinking Water
Volume: 12 Issue: 3
Author(s): Magda Caban, Anna Bialk-Bielinska, Piotr Stepnowski and Jolanta Kumirska
Affiliation:
Keywords: Drinking water, legislation, pharmaceutical residues, risk assessment, trace analysis.
Abstract: The presence of pharmaceuticals in drinking water has been a subject of concern for the last ten years because many of these pollutants are persistent in such aquatic matrices. Latest studies have shown that they can pose a ecotoxicological risk due to their potential long-term negative effects on living organism, even though the relatively low concentrations of these compounds in drinking water (ng/L). For this reason, several researchers have been investigating the roles of various drinking water treatment (DWT) processes in the efficiency of these polar pollutants elimination to decrease their release into the drinking water system. What more, from several years the monitoring programs and advance risk assessment are being carried out in order to gives important information for indicators finding (for future monitoring) and consequential regulations. This study critically reviews available literature on pharmaceutical residues in drinking water, starting from their occurrence, fate and finally toxicology significance. Presented review is also presenting the issue of pharmaceuticals detection and products occurred after drinking water treatment. Moreover, it is also intended to provide an proposition into what future directions might be taken by drinking-water regulators, governments, and water suppliers in their challenging task of enhancing the availability of data on the fate, behavior, and ecotoxicity of pharmaceutical residues in drinking water, in order to be fully aware of the potential risks to humans from exposure to traces of pharmaceuticals via drinking water.
Export Options
About this article
Cite this article as:
Caban Magda, Bialk-Bielinska Anna, Stepnowski Piotr and Kumirska Jolanta, Current Issues in Pharmaceutical Residues in Drinking Water, Current Analytical Chemistry 2016; 12 (3) . https://dx.doi.org/10.2174/1573411012666151009194401
DOI https://dx.doi.org/10.2174/1573411012666151009194401 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Organelle Stress Sensors and Cell Death Mechanisms in Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Zoledronic Acid -a Multiplicity of Anti-Cancer Action
Current Medicinal Chemistry Membrane Targeted Chemotherapy with Hybrid Liposomes for Tumor Cells Leading to Apoptosis
Current Pharmaceutical Design Structural Approaches to Explain the Selectivity of COX-2 Inhibitors: Is There a Common Pharmacophore?
Current Medicinal Chemistry New Molecular Targets in the Treatment of NSCLC
Current Pharmaceutical Design Current Trends in the Application of Nanoparticles in Drug Delivery
Current Medicinal Chemistry Cyclodextrins for Non-Viral Gene and siRNA Delivery
Pharmaceutical Nanotechnology Management Options in Childhood Asthma – What is the Current Evidence on which Treatment is Based?
Current Pediatric Reviews Anal Carcinoma
Current Cancer Therapy Reviews The Role of Oxazolidine Derivatives in the Treatment of Infectious and Chronic Diseases
Current Bioactive Compounds Statin-induced Vascular Smooth Muscle Cell Apoptosis: A Possible Role in the Prevention of Restenosis?
Current Drug Targets - Cardiovascular & Hematological Disorders Novel Strategies for Development of Next-Generation Glycoconjugate Vaccines
Current Topics in Medicinal Chemistry Pathophysiological Implications of Dipeptidyl Peptidases
Current Protein & Peptide Science New Targets for Therapy in Polyglutamine (polyQ) Expansion Diseases
Current Drug Therapy The Role of the Endothelium in the Pathogenesis of Atherosclerosis and its Therapeutic Implications
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Ca<sup>2+</sup>/Calmodulin-Dependent Protein Kinase- II in Vasoactive Peptide- Induced Responses and Vascular Biology
Current Vascular Pharmacology Protein-Protein Interactions: Recent Progress in the Development of Selective PDZ Inhibitors
Current Chemical Biology Immunomodulation in Trichinellosis: Does Trichinella Really Escape the Host Immune System?
Endocrine, Metabolic & Immune Disorders - Drug Targets Endocannabinoids in Appetite Control and the Treatment of Obesity
CNS & Neurological Disorders - Drug Targets Subcellular Trafficking in Rhabdovirus Infection and Immune Evasion: A Novel Target for Therapeutics
Infectious Disorders - Drug Targets